Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Astec Industries | ASTE | Nov 27, 2024 | 38.34 | +0.16 |
Astera Labs | ALAB | Nov 27, 2024 | 99.60 | -5.57 |
Astrana Health | ASTH | Nov 27, 2024 | 42.86 | +0.94 |
AstraZeneca ADR | AZN | Nov 27, 2024 | 67.20 | +1.27 |
Astria Therapeutics | ATXS | Nov 27, 2024 | 10.50 | +1.94 |
Astronics | ATRO | Nov 27, 2024 | 16.04 | +2.43 |
AstroNova | ALOT | Nov 27, 2024 | 15.02 | -1.12 |
Astrotech | ASTC | Nov 27, 2024 | 7.45 | -3.37 |
Asure Software | ASUR | Nov 27, 2024 | 9.82 | +1.76 |
AT&T | T | Nov 27, 2024 | 23.27 | +0.78 |
AT&T A Pref | T-A | Nov 27, 2024 | 21.36 | +0.19 |
AT&T C Pref | T-C | Nov 27, 2024 | 20.18 | -0.15 |
ATA Creativity Global ADR | AACG | Nov 27, 2024 | 1.00 | -1.47 |
Atai Life Sciences BV | ATAI | Nov 27, 2024 | 1.73 | +2.37 |
Atara Biotherapeutics | ATRA | Nov 27, 2024 | 12.18 | -0.65 |
Atea Pharmaceuticals | AVIR | Nov 27, 2024 | 3.46 | +4.85 |
Aterian | ATER | Nov 27, 2024 | 2.70 | +5.06 |
Athena Technology Acquisition II | ATEK | Nov 27, 2024 | 11.81 | -1.01 |
Athene A Pref | ATH-A | Nov 27, 2024 | 25.13 | -0.28 |
Athene B Pref | ATH-B | Nov 27, 2024 | 21.92 | +0.69 |
Athene C Pref | ATH-C | Nov 27, 2024 | 25.32 | +0.08 |
Athene D Pref | ATH-D | Nov 27, 2024 | 19.13 | +0.10 |
Athene Holding | ATH-E | Nov 27, 2024 | 26.89 | +0.53 |
Athira Pharma | ATHA | Nov 27, 2024 | 0.65 | +5.32 |
Ati Physical Therapy A | ATIP | Nov 27, 2024 | 1.67 | -2.34 |
ATIF Holdings | ATIF | Nov 27, 2024 | 0.62 | 0.00 |
Atkore | ATKR | Nov 27, 2024 | 93.17 | -1.87 |
Atlanta Braves A | BATRA | Nov 27, 2024 | 41.95 | +0.38 |
Atlanta Braves C | BATRK | Nov 27, 2024 | 40.14 | +0.15 |
Atlantic American | AAME | Nov 27, 2024 | 1.56 | +1.96 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.